CFO: We are reaping the benefits of five years work
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article3000686.ece/ALTERNATES/schema-16_9/GREGERS.OVERVAD.Jyllandsposten2.jpg)
2012 was a great year for Xellia Pharmaceuticals’ Danish business unit, which boasted a turnover of 918 million kroner (USD 160 million) and an operating profit of 147 million kroner (USD 25.6 million).
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.